Roku, Intel And Some Other Big Stocks Moving Lower In Today’s Pre-Market Session
Roku, Inc. (NASDAQ:ROKU) shares fell 24.3% to $64.45 in pre-market trading after the company reported weaker-than-expected financial results…
Piper Sandler Maintains Overweight on Edwards Lifesciences, Lowers Price Target to $120
Piper Sandler analyst Adam Maeder maintains Edwards Lifesciences (NYSE:EW) with a Overweight and lowers the price target from $125 to $120.
Canaccord Genuity Downgrades Edwards Lifesciences to Hold, Lowers Price Target to $106
Canaccord Genuity analyst William Plovanic downgrades Edwards Lifesciences (NYSE:EW) from Buy to Hold and lowers the price target from $115 to $106.
Edwards Lifesciences Shares Slide As Q2 Results Miss Expectations, Lowers FY22 Sales Outlook
Edwards Lifesciences Corp (NYSE:EW) reported second-quarter sales of $1.37 billion, flat compared to 2Q21, missing the consensus of $1.4 billion.…
Truist Securities Maintains Buy on Edwards Lifesciences, Lowers Price Target to $120
Truist Securities analyst Richard Newitter maintains Edwards Lifesciences (NYSE:EW) with a Buy and lowers the price target from $140 to $120.
Expert Ratings for Edwards Lifesciences
Analysts have provided the following ratings for Edwards Lifesciences (NYSE:EW) within the last quarter:
Looking Into Edwards Lifesciences’s Recent Short Interest
Edwards Lifesciences's (NYSE:EW) short percent of float has fallen 64.56% since its last report. The company recently reported that it has 6.21 million shares sold short, which is 1.01% of all regular shares that are available for trading.
Stifel Maintains Buy on Edwards Lifesciences, Lowers Price Target to $115
Stifel analyst Rick Wise maintains Edwards Lifesciences (NYSE:EW) with a Buy and lowers the price target from $128 to $115.
Morgan Stanley Maintains Overweight on Edwards Lifesciences, Lowers Price Target to $119
Morgan Stanley analyst Cecilia Furlong maintains Edwards Lifesciences (NYSE:EW) with a Overweight and lowers the price target from $136 to $119.